CellaVision AB
STO:CEVI
CellaVision AB
STO:CEVI
Price:
226 SEK
0.22%
Market Closed
Updated:
May 2, 2024
CellaVision AB
Cash from Financing Activities
|
CellaVision AB
Cash from Financing Activities Peer Comparison
Comparables:
EKTA B
GETI B
ARJO B
ELOS B
SEDANA
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
CellaVision AB
STO:CEVI
|
Cash from Financing Activities
-kr97m
|
CAGR 3-Years
-40%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
-38%
|
|
|
Elekta AB (publ)
STO:EKTA B
|
Cash from Financing Activities
-kr129m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
|
|
Getinge AB
STO:GETI B
|
Cash from Financing Activities
kr511m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Arjo AB (publ)
STO:ARJO B
|
Cash from Financing Activities
-kr1.4B
|
CAGR 3-Years
-14%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Elos Medtech AB
STO:ELOS B
|
Cash from Financing Activities
kr74m
|
CAGR 3-Years
333%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Sedana Medical AB (publ)
STO:SEDANA
|
Cash from Financing Activities
-kr4.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is CellaVision AB's Cash from Financing Activities?
Cash from Financing Activities
-97m
SEK
-97m
SEK
Based on the financial report for Dec 31, 2023, CellaVision AB's Cash from Financing Activities amounts to -97m SEK.
What is CellaVision AB's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
-38%
-38%
Over the last year, the Cash from Financing Activities growth was -7%. The average annual Cash from Financing Activities growth rates for CellaVision AB have been -40% over the past three years , -22% over the past five years , and -38% over the past ten years .
You don't have any saved screeners yet
